Literature DB >> 10706618

The retinoblastoma-interacting zinc-finger protein RIZ is a downstream effector of estrogen action.

C Abbondanza1, N Medici, V Nigro, V Rossi, L Gallo, G Piluso, A Belsito, A Roscigno, P Bontempo, A A Puca, A M Molinari, B Moncharmont, G A Puca.   

Abstract

Co-immunoprecipitation experiments in cell extract from cultured cells or target tissues indicated that estrogen receptor was complexed with the retinoblastoma binding protein RIZ in a ligand-dependent manner. Mapping of interaction sites indicated that in both proteins the same regions and motifs responsible for the interaction of transcriptional co-activator and nuclear receptors were involved. In cultured cells, estradiol induced a redistribution of RIZ protein within the nucleus and in the cytoplasm. A similar effect was produced in vivo, in prepuberal rat endometrium, by administration of a physiological dose of estradiol. Therefore, RIZ protein could be a specific effector of estrogen action downstream of the hormone-receptor interaction, presumably involved in proliferation control.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10706618      PMCID: PMC16204          DOI: 10.1073/pnas.97.7.3130

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Repression of RNA polymerase III transcription by the retinoblastoma protein.

Authors:  R J White; D Trouche; K Martin; S P Jackson; T Kouzarides
Journal:  Nature       Date:  1996-07-04       Impact factor: 49.962

2.  Physical mapping of the retinoblastoma interacting zinc finger gene RIZ to D1S228 on chromosome 1p36.

Authors:  I M Buyse; E I Takahashi; S Huang
Journal:  Genomics       Date:  1996-05-15       Impact factor: 5.736

3.  A signature motif in transcriptional co-activators mediates binding to nuclear receptors.

Authors:  D M Heery; E Kalkhoven; S Hoare; M G Parker
Journal:  Nature       Date:  1997-06-12       Impact factor: 49.962

4.  Interaction of proteins with transcriptionally active estrogen receptors.

Authors:  V Cavaillès; S Dauvois; P S Danielian; M G Parker
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

Review 5.  Regulation of RNA polymerases I and III by the retinoblastoma protein: a mechanism for growth control?

Authors:  R J White
Journal:  Trends Biochem Sci       Date:  1997-03       Impact factor: 13.807

6.  TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors.

Authors:  J J Voegel; M J Heine; C Zechel; P Chambon; H Gronemeyer
Journal:  EMBO J       Date:  1996-07-15       Impact factor: 11.598

7.  The retinoblastoma interacting zinc finger gene RIZ produces a PR domain-lacking product through an internal promoter.

Authors:  L Liu; G Shao; G Steele-Perkins; S Huang
Journal:  J Biol Chem       Date:  1997-01-31       Impact factor: 5.157

8.  17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells.

Authors:  L Altucci; R Addeo; L Cicatiello; S Dauvois; M G Parker; M Truss; M Beato; V Sica; F Bresciani; A Weisz
Journal:  Oncogene       Date:  1996-06-06       Impact factor: 9.867

9.  Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1.

Authors:  E vom Baur; C Zechel; D Heery; M J Heine; J M Garnier; V Vivat; B Le Douarin; H Gronemeyer; P Chambon; R Losson
Journal:  EMBO J       Date:  1996-01-02       Impact factor: 11.598

10.  Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells.

Authors:  A Migliaccio; M Di Domenico; G Castoria; A de Falco; P Bontempo; E Nola; F Auricchio
Journal:  EMBO J       Date:  1996-03-15       Impact factor: 11.598

View more
  14 in total

1.  Structural and functional characterization of the acidic region from the RIZ tumor suppressor.

Authors:  Yizhi Sun; Jessica M Stine; Daniel Z Atwater; Ayesha Sharmin; J B Alexander Ross; Klára Briknarová
Journal:  Biochemistry       Date:  2015-02-02       Impact factor: 3.162

2.  Functional interactions between the estrogen receptor coactivator PELP1/MNAR and retinoblastoma protein.

Authors:  Seetharaman Balasenthil; Ratna K Vadlamudi
Journal:  J Biol Chem       Date:  2003-04-07       Impact factor: 5.157

3.  Genetic and epigenetic alterations of RIZ1 and the correlation to clinicopathological parameters in liver fluke-related cholangiocarcinoma.

Authors:  Prasong Khaenam; Patcharee Jearanaikoon; Chawalit Pairojkul; Vajarabhongsa Bhudhisawasdi; Temduang Limpaiboon
Journal:  Exp Ther Med       Date:  2010-03-01       Impact factor: 2.447

4.  Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein-methyltransferase superfamily.

Authors:  G Steele-Perkins; W Fang; X H Yang; M Van Gele; T Carling; J Gu; I M Buyse; J A Fletcher; J Liu; R Bronson; R B Chadwick; A de la Chapelle; X Zhang; F Speleman; S Huang
Journal:  Genes Dev       Date:  2001-09-01       Impact factor: 11.361

5.  Estrogens and progesterone promote persistent CCND1 gene activation during G1 by inducing transcriptional derepression via c-Jun/c-Fos/estrogen receptor (progesterone receptor) complex assembly to a distal regulatory element and recruitment of cyclin D1 to its own gene promoter.

Authors:  Luigi Cicatiello; Raffaele Addeo; Annarita Sasso; Lucia Altucci; Valeria Belsito Petrizzi; Raphaelle Borgo; Massimo Cancemi; Simona Caporali; Silvana Caristi; Claudio Scafoglio; Diana Teti; Francesco Bresciani; Bruno Perillo; Alessandro Weisz
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

6.  A histone methyltransferase is required for maximal response to female sex hormones.

Authors:  Tobias Carling; Keun-Cheol Kim; Xiao-Hong Yang; Jian Gu; Xiao-Kun Zhang; Shi Huang
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

Review 7.  Epigenetic targeting in breast cancer: therapeutic impact and future direction.

Authors:  M B Lustberg; B Ramaswamy
Journal:  Drug News Perspect       Date:  2009-09

8.  Detection of frameshift mutations of RIZ in gastric cancers with microsatellite instability.

Authors:  Kai-Feng Pan; You-Yong Lu; Wan-Guo Liu; Lian Zhang; Wei-Cheng You
Journal:  World J Gastroenterol       Date:  2004-09-15       Impact factor: 5.742

9.  Preferential loss of a polymorphic RIZ allele in human hepatocellular carcinoma.

Authors:  W Fang; Z Piao; I M Buyse; D Simon; J C Sheu; M Perucho; S Huang
Journal:  Br J Cancer       Date:  2001-03-23       Impact factor: 7.640

10.  The p75NTR-interacting protein SC1 inhibits cell cycle progression by transcriptional repression of cyclin E.

Authors:  Alexandra Chittka; Juan Carlos Arevalo; Maria Rodriguez-Guzman; Pilar Pérez; Moses V Chao; Michael Sendtner
Journal:  J Cell Biol       Date:  2004-03-29       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.